1.32
price up icon0.00%   0.00
after-market アフターアワーズ: 1.31 -0.01 -0.76%
loading
前日終値:
$1.32
開ける:
$1.34
24時間の取引高:
1.89M
Relative Volume:
0.57
時価総額:
$1.09B
収益:
$711.41M
当期純損益:
$-133.73M
株価収益率:
-6.9474
EPS:
-0.19
ネットキャッシュフロー:
$-199.99M
1週間 パフォーマンス:
+3.94%
1か月 パフォーマンス:
-2.94%
6か月 パフォーマンス:
-10.20%
1年 パフォーマンス:
+5.60%
1日の値動き範囲:
Value
$1.30
$1.34
1週間の範囲:
Value
$1.26
$1.34
52週間の値動き範囲:
Value
$1.19
$2.035

Opko Health Inc Stock (OPK) Company Profile

Name
名前
Opko Health Inc
Name
セクター
Healthcare (1173)
Name
電話
305-575-4181
Name
住所
4400 BISCAYNE BLVD., MIAMI, FL
Name
職員
2,997
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
OPK's Discussions on Twitter

OPK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
OPK
Opko Health Inc
1.32 1.09B 711.41M -133.73M -199.99M -0.19
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
405.46 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
197.54 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
536.34 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
118.01 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
157.59 27.64B 15.50B 1.33B 2.16B 7.34

Opko Health Inc Stock (OPK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-25 開始されました JP Morgan Neutral
2023-06-29 アップグレード Barrington Research Mkt Perform → Outperform
2022-12-15 開始されました H.C. Wainwright Buy
2022-01-24 ダウングレード Barrington Research Outperform → Mkt Perform
2021-06-21 開始されました Ladenburg Thalmann Buy
2019-11-25 開始されました Piper Jaffray Overweight
2018-03-02 ダウングレード JP Morgan Neutral → Underweight
2017-09-14 ダウングレード JP Morgan Overweight → Neutral
2016-06-21 繰り返されました Standpoint Research Buy
2016-06-03 開始されました Standpoint Research Buy
2016-03-31 繰り返されました Barrington Research Outperform
2015-10-16 開始されました JP Morgan Overweight
2015-09-11 ダウングレード Jefferies Buy → Hold
2015-03-03 ダウングレード Oppenheimer Outperform → Perform
2014-05-12 繰り返されました Oppenheimer Outperform
2014-03-14 開始されました Oppenheimer Outperform
2013-11-13 繰り返されました Ladenburg Thalmann Buy
2013-05-30 繰り返されました Ladenburg Thalmann Buy
2012-10-22 開始されました Barrington Research Outperform
2011-12-01 繰り返されました Ladenburg Thalmann Buy
2011-07-14 開始されました Ladenburg Thalmann Buy
すべてを表示

Opko Health Inc (OPK) 最新ニュース

pulisher
Jun 18, 2025

Shareholders in OPKO Health (NASDAQ:OPK) have lost 51%, as stock drops 6.5% this past week - simplywall.st

Jun 18, 2025
pulisher
Jun 14, 2025

Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN

Jun 14, 2025
pulisher
Jun 13, 2025

Quote - OPKO Health, Inc.

Jun 13, 2025
pulisher
Jun 13, 2025

Bone Cancer Drugs Market Set to Witness Significant Growth - openPR.com

Jun 13, 2025
pulisher
Jun 13, 2025

Bank of America Corp DE Has $855,000 Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jun 13, 2025
pulisher
Jun 11, 2025

OPKO Health: Strong Pipeline Of Drugs, But Not Rushing To Buy (NASDAQ:OPK) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 09, 2025

ModeX assembles advisory board for antibody development By Investing.com - Investing.com India

Jun 09, 2025
pulisher
Jun 09, 2025

ModeX assembles advisory board for antibody development - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

OPKO Health's ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development - The Manila Times

Jun 09, 2025
pulisher
Jun 09, 2025

OPKO Health's (OPK) ModeX Therapeutics Forms Scientific Advisory Board - StreetInsider

Jun 09, 2025
pulisher
Jun 09, 2025

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development - GlobeNewswire Inc.

Jun 09, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Boosts Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jun 06, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Cuts Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jun 05, 2025
pulisher
Jun 04, 2025

OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Two Sigma Investments LP - MarketBeat

Jun 04, 2025
pulisher
Jun 04, 2025

Peptide Therapeutics Market Growth Set to Surge Significantly - openPR.com

Jun 04, 2025
pulisher
Jun 03, 2025

Opko health outlines $675M-$685M revenue guidance for 2025 amid strategic initiatives - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

Bone Cancer Drugs Market in 2025-2032 Detailed Study Analysis - openPR.com

Jun 03, 2025
pulisher
Jun 02, 2025

BNP Paribas Financial Markets Sells 195,118 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 8,064 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Q2 EPS Estimates for OPKO Health Reduced by Zacks Research - MarketBeat

May 31, 2025
pulisher
May 31, 2025

Millennium Management LLC Boosts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

May 31, 2025
pulisher
May 30, 2025

Deutsche Bank AG Grows Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

May 30, 2025
pulisher
May 29, 2025

Opko Health grants stock options, approves bonuses - Investing.com India

May 29, 2025
pulisher
May 29, 2025

Opko Health grants stock options, approves bonuses By Investing.com - Investing.com Nigeria

May 29, 2025
pulisher
May 29, 2025

Opko Health Grants Stock Options and Bonuses - TipRanks

May 29, 2025
pulisher
May 28, 2025

OPKO Health (OPK) Rises with Promising Oncology Developments - GuruFocus

May 28, 2025
pulisher
May 28, 2025

SA Asks: What are the best oncology stocks right now? - Seeking Alpha

May 28, 2025
pulisher
May 27, 2025

Millennium Management LLC Boosts Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

May 27, 2025
pulisher
May 26, 2025

Down Syndrome Market: Epidemiology, Therapies, Companies, - openPR.com

May 26, 2025
pulisher
May 24, 2025

What OPKO Health, Inc.'s (NASDAQ:OPK) P/S Is Not Telling You - simplywall.st

May 24, 2025
pulisher
May 22, 2025

Hyperparathyroidism Treatment Market: Effective Treatment - openPR.com

May 22, 2025
pulisher
May 22, 2025

OPKO Health, Inc. (NASDAQ:OPK) Shares Acquired by Lazard Asset Management LLC - MarketBeat

May 22, 2025
pulisher
May 20, 2025

Opko Health at BioConnect: Strategic Shifts and Financial Insights By Investing.com - Investing.com India

May 20, 2025
pulisher
May 18, 2025

Opko Completes Prolor Deal - Medical Product Outsourcing

May 18, 2025
pulisher
May 18, 2025

Mercer Global Advisors Inc. ADV Grows Stake in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

May 18, 2025
pulisher
May 17, 2025

Strong week for OPKO Health (NASDAQ:OPK) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance

May 17, 2025
pulisher
May 15, 2025

Esoteric Testing Market Set to Witness Significant Growth - openPR.com

May 15, 2025
pulisher
May 15, 2025

OPKO Health to Participate in Two Upcoming Investor Conferences - GlobeNewswire

May 15, 2025
pulisher
May 14, 2025

Dimensional Fund Advisors LP Lowers Position in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

May 14, 2025

Opko Health Inc (OPK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Opko Health Inc (OPK) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
FROST PHILLIP MD ET AL
CEO & Chairman
Apr 08 '25
Buy
1.48
125,000
184,650
213,876,448
FROST PHILLIP MD ET AL
CEO & Chairman
Apr 01 '25
Buy
1.65
100,000
164,850
213,751,448
FROST PHILLIP MD ET AL
CEO & Chairman
Mar 28 '25
Buy
1.70
150,000
254,385
213,651,448
FROST PHILLIP MD ET AL
CEO & Chairman
Mar 17 '25
Buy
1.74
200,000
347,820
213,501,448
FROST PHILLIP MD ET AL
CEO & Chairman
Feb 28 '25
Buy
1.71
67,434
115,312
213,301,448
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 28 '25
Buy
1.47
47,537
70,060
213,234,014
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 17 '25
Buy
1.47
150,000
220,425
213,186,477
FROST PHILLIP MD ET AL
CEO & Chairman
Jan 15 '25
Buy
1.48
500,000
740,850
213,036,477
FROST PHILLIP MD ET AL
CEO & Chairman
Dec 13 '24
Buy
1.59
125,000
199,375
212,536,477
FROST PHILLIP MD ET AL
CEO & Chairman
Dec 11 '24
Buy
1.56
500,000
781,050
212,411,477
diagnostics_research DGX
$179.63
price up icon 1.01%
diagnostics_research WAT
$349.04
price down icon 0.96%
diagnostics_research LH
$262.51
price up icon 0.74%
$168.94
price up icon 0.58%
diagnostics_research MTD
$1,174.72
price down icon 0.83%
diagnostics_research IQV
$157.59
price up icon 0.08%
大文字化:     |  ボリューム (24 時間):